Evidence map›Paper›PMID 24955285›Full record

ArticleInternational journal of biochemistry and molecular biology2014

The interaction of the ErbB4 intracellular domain p80 with α-enolase in the nuclei is associated with the inhibition of the neuregulin1-dependent cell proliferation.

Satomi Yamada, Masaki Marutsuka, Miyabi Inoue, Jidong Zhang, Shin-Ichi Abe, Ken-Ichi Ishibashi, Naoto Yamaguchi, Ko Eto

Open access · greenAbstract read
In one paragraph

Article in International journal of biochemistry and molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. The role of ErbB4 in cancer.Cellular oncology (Dordrecht, Netherlands) · 2020
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Satomi YamadaDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
Masaki MarutsukaDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
Miyabi InoueDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
Jidong ZhangDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
Shin-Ichi AbeDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
Ken-Ichi IshibashiDepartment of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.
Naoto YamaguchiDepartment of Molecular Cell Biology, Graduate School of Pharmaceutical Sciences, Chiba University 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.
Ko EtoDepartment of Biological Sciences, Graduate School of Science and Technology, Kumamoto University 2-39-1 Kurokami, Chuo-ku, Kumamoto 860-8555, Japan.
Kumamoto University · JPChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have shown that the receptor tyrosine kinase ErbB4 signals neuregulin1-stimulated proliferation of human cells. Some isoforms of ErbB4 are cleaved to release the soluble intracellular domain p80; however, the function of p80 in cell proliferation remained unclear. Here we propose the possibility for p80 as a negative feedback modulator of ErbB4-mediated cell proliferation. Cells exposed to lower doses of neuregulin1 displayed a stimulated proliferation and contained ErbB4 but barely p80. By contrast, cells exposed to its higher doses displayed a suppressed proliferation and contained p80 but barely ErbB4. Analyses with cells overexpressing the p80 wild type and mutants indicated that nuclear p80 inhibits cell proliferation independently of the tyrosine kinase activity. A screen for a novel protein that interacts with p80 identified α-enolase, which is reported as a transcriptional inhibitor for the proliferation-associated c-myc gene. The c-myc mRNA expression was induced by lower doses of neuregulin1 but was suppressed by its higher doses. Subcellular fractionation demonstrated the localization of not only p80 and α-enolase but also the decrease of the functional c-myc amount in the nuclei of cells exposed to higher doses of neuregulin1. These results suggested that p80, which is generated from ErbB4 and translocates to the nuclei, interacts with α-enolase and inhibits neuregulin1-dependent ErbB4-mediated cell proliferation by impairing the c-myc gene transcription.

Indexed as

cell proliferationGrowth factorintracellular domain signalingreceptor tyrosine kinasetranscriptional regulator

Identifiers

PMID24955285
PMCPMC4058961
OpenAlexW1009650268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.